Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications.
about
Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cells.Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.Developing defined substrates for stem cell culture and differentiation.Selective Elimination of Culture-Adapted Human Embryonic Stem Cells with BH3 Mimetics
P2860
Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Assessing the Safety of Human ...... ves for Clinical Applications.
@en
Assessing the Safety of Human ...... ves for Clinical Applications.
@nl
type
label
Assessing the Safety of Human ...... ves for Clinical Applications.
@en
Assessing the Safety of Human ...... ves for Clinical Applications.
@nl
prefLabel
Assessing the Safety of Human ...... ves for Clinical Applications.
@en
Assessing the Safety of Human ...... ves for Clinical Applications.
@nl
P2093
P1433
P1476
Assessing the Safety of Human ...... ives for Clinical Applications
@en
P2093
Andras Nagy
Barbara B Knowles
Glyn N Stacey
Kevin Eggan
Martin Pera
Nissim Benvenisty
Peter Coffey
Peter W Andrews
Uri Ben-David
P356
10.1016/J.STEMCR.2017.05.029
P577
2017-07-01T00:00:00Z